Potential Predictors of Cardiovascular Risk Improvement in Patients with Hidradenitis Suppurativa Treated with Adalimumab: A Pivotal Study of Factors Associated with Carotid Intima–Media Thickness Reduction

INTRODUCTION: Hidradenitis suppurativa (HS) has been linked to higher cardiovascular risk (CVR) due to its inflammatory burden. There is little evidence on how biologic treatment could modify the cardiovascular risk of patients with HS. The aims of the present study were to explore the modification...

Descripción completa

Detalles Bibliográficos
Autores principales: Sánchez-Díaz, Manuel, Salvador-Rodríguez, Luis, Cuenca-Barrales, Carlos, Arias-Santiago, Salvador, Molina-Leyva, Alejandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9984601/
https://www.ncbi.nlm.nih.gov/pubmed/36787042
http://dx.doi.org/10.1007/s13555-023-00898-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9984601/
https://www.ncbi.nlm.nih.gov/pubmed/36787042
http://dx.doi.org/10.1007/s13555-023-00898-z

Ejemplares similares